New York, NY, United States of America

Andrew Placzek

This inventor holds 1 USPTO granted patent. Top assignee: Schrodinger, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Placzek. Retrieved from https://idiyas.com/inventor/andrew-placzek-855v6zad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Placzek: Innovator in Cancer Treatment

Introduction

Andrew Placzek is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the development of compounds that can aid in the treatment of serious health conditions.

Latest Patents

Andrew holds a patent for "Tricyclic Compounds Useful in the Treatment of Cancer, Autoimmune and Inflammatory Disorders." This innovative work showcases his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name, reflecting his dedication to research and development.

Career Highlights

Currently, Andrew is employed at Schrodinger, LLC, where he continues to work on groundbreaking projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical research.

Collaborations

Andrew has worked alongside colleagues such as Shulu Feng and Morgan Lawrenz. These collaborations have been instrumental in driving forward the research initiatives at Schrodinger, LLC.

Conclusion

Andrew Placzek is a dedicated inventor whose work in developing tricyclic compounds is paving the way for new treatments in cancer and autoimmune disorders. His contributions to the field are invaluable and highlight the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…